Spire Healthcare Group (LON:SPI) Reaches New 52-Week High – Here’s Why

Spire Healthcare Group plc (LON:SPI – Get Free Report) shares reached a new 52-week high during mid-day trading on Monday. The stock traded as high as GBX 249.50 and last traded at GBX 248.50, with a volume of 1,619,336 shares trading hands. The stock had previously closed at GBX 249.

Analyst Upgrades and Downgrades

Separately, Royal Bank Of Canada downgraded shares of Spire Healthcare Group to a “sector perform” rating and reduced their price objective for the company from GBX 300 to GBX 250 in a research note on Monday, September 7th. One analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of GBX 247.50.

Get Our Latest Stock Analysis on SPI

Spire Healthcare Group Trading Up 0.2%

The company has a current ratio of 0.58, a quick ratio of 0.73 and a debt-to-equity ratio of 180.14. The company has a market cap of £995.49 million, a price-to-earnings ratio of -497.00, a price-to-earnings-growth ratio of 1.06 and a beta of 0.93. The firm has a 50-day moving average price of GBX 245.05 and a 200 day moving average price of GBX 210.14.

Spire Healthcare Group (LON:SPI – Get Free Report) last announced its quarterly earnings data on Wednesday, September 30th. The company reported GBX (0.50) earnings per share (EPS) for the quarter. Spire Healthcare Group had a negative return on equity of 0.26% and a negative net margin of 0.12%. As a group, sell-side analysts forecast that Spire Healthcare Group plc will post 15.66 EPS for the current year.

Spire Healthcare Group Company Profile

(Get Free Report)

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.

Further Reading

• Five stocks we like better than Spire Healthcare Group
• Tower Semiconductor’s Earnings Are Soaring—So Why Is Its Stock Down More Than 50%?
• Shopify’s Small Q3 Miss Triggered a Big Sell-Off: What’s Next?
• Can Oil’s Big Rally Deliver Reliable Income? 3 Energy Plays to Watch
• Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand

Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.